Cargando…
TET2–BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter
Ascl2 has been shown to be involved in tumorigenesis in colorectal cancer (CRC), although its epigenetic regulatory mechanism is largely unknown. Here, we found that methylation of the Ascl2 promoter (bp -1670 ∼ -1139) was significantly increased compared to the other regions of the Ascl2 locus in C...
Autores principales: | Shang, Yangyang, Jiang, Tao, Ran, Lijian, Hu, Wenjing, Wu, Yun, Ye, Jun, Peng, Zhihong, Chen, Lei, Wang, Rongquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251787/ https://www.ncbi.nlm.nih.gov/pubmed/35660018 http://dx.doi.org/10.1016/j.jbc.2022.102095 |
Ejemplares similares
-
Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells
por: Wei, Xiaolong, et al.
Publicado: (2017) -
In Search of a Function for BCLAF1
por: Sarras, Haya, et al.
Publicado: (2010) -
Function of BCLAF1 in human disease
por: Yu, Zongdong, et al.
Publicado: (2022) -
Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma
por: Wen, Ying, et al.
Publicado: (2018) -
BCLAF1 induces cisplatin resistance in lung cancer cells
por: Jiang, Tao, et al.
Publicado: (2020)